{"name":"ProEthic Pharmaceuticals","slug":"proethic-pharmaceuticals","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"PRO-513","genericName":"PRO-513","slug":"pro-513","indication":"Type 2 diabetes","status":"phase_3"}]}],"pipeline":[{"name":"PRO-513","genericName":"PRO-513","slug":"pro-513","phase":"phase_3","mechanism":"PRO-513 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTFBKOFBNWlZ6XzZKYktMREY1bEFRUEpjSzFNYjZkV01RWFJOYXM5WTJkdVJYMEVuM0V1eWthRTFoeDhfWmItalJESGN0clNlVFJUNDlTa0ZWWVN5bTNxVnVXX3FfWjVLaHU0T2Q1aw?oc=5","date":"2022-01-12","type":"pipeline","source":"Pharma Voice","summary":"Talent Pool - Pharma Voice","headline":"Talent Pool","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiW0FVX3lxTE5WN2pPRW5qQkZOWTB4bGtDbTF0VXBEMVRFSmV4WWV2YXpLWVQyd2plRWdHUzd6R3dZd3ljM0hYdG1Ec2RTVVNYVlZncW1UQ1k5dTFDekt3Y3FMZUE?oc=5","date":"2020-04-14","type":"patent","source":"Business Alabama Magazine","summary":"Strategic Generics - Business Alabama Magazine","headline":"Strategic Generics","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}